Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Epstein-Barr Virus Infections 1

Interventions

pembrolizumab 4Cisplatin 4nedaplatin 2Heavy Ion Radiotherapy 2Gemcitabine 2donafenib 1apatinib 1Varenicline 1Valganciclovir 1Therapeutics 1Tegafur 1S 1 (combination) 1Platinum 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Nicotine Replacement Therapy 1Mitomycin 1Ifosfamide 1Fluorouracil 1Eucalyptus Oil 1Epirubicin 1Doxorubicin 1Coal Tar 1Chemotherapy, Adjuvant 1Cetuximab 1Carboplatin 1Bupropion 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Nasopharyngeal Carcinoma × Tegafur × Clear all
NCT02363400 2025-08-19

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

National Health Research Institutes, Taiwan

Phase 3 Terminated
10 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡